LYPLA2 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O95372 |
---|---|
Clone Names | 110729132 |
Gene ID | 11313 |
---|---|
Other Names | Acyl-protein thioesterase 2, APT-2, 312-, Lysophospholipase II, LPL-II, LysoPLA II, LYPLA2, APT2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | LYPLA2 |
---|---|
Synonyms | APT2 |
Function | Acts as an acyl-protein thioesterase hydrolyzing fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins, GAP43, ZDHHC6 or HRAS (PubMed:21152083, PubMed:28826475). Deacylates GAP43 (PubMed:21152083). Mediates depalmitoylation of ZDHHC6 (PubMed:28826475). Has lysophospholipase activity (PubMed:25301951). Hydrolyzes prostaglandin glycerol esters (PG-Gs) in the following order prostaglandin D2-glycerol ester (PGD2-G) > prostaglandin E2 glycerol ester (PGE2-G) > prostaglandin F2-alpha-glycerol ester (PGF2-alpha-G) (PubMed:25301951). Hydrolyzes 1-arachidonoylglycerol but not 2- arachidonoylglycerol or arachidonoylethanolamide (PubMed:25301951). |
Cellular Location | Cytoplasm. |
Tissue Location | Expressed in various breast cancer cell lines. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Lysophospholipases are enzymes that act on biologicalmembranes to regulate the multifunctional lysophospholipids. Thereare alternatively spliced transcript variants described for thisgene but the full length nature is not known yet. [provided byRefSeq].
References
Ma, J., et al. Atherosclerosis 191(1):63-72(2007)Wang, A., et al. Biochim. Biophys. Acta 1439(1):1-16(1999)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.